Nicotine replacement therapy for smoking cessation
159 results
42 - 141
Smoking cessation 
Varenicline plus nicotine replacement therapy more effective than varenicline alone
Opioid antagonists for smoking cessation- Nicotine replacement with e-cigarettes might help smokers quit
- Silver acetate for smoking cessation
- Electronic nicotine-delivery systems increase abstinence in tobacco users (NNT = 6 - 8)
- Smoking cessation for chronic obstructive pulmonary disease
- Electronic cigarettes for smoking cessation
- Nicotine receptor partial agonists for smoking cessation
- Workplace interventions for smoking cessation
- Pharmacological and electronic cigarette interventions for smoking cessation in adults: component network meta‐analyses
- Clonidine for smoking cessation
- Pharmacological interventions for promoting smoking cessation during pregnancy
- American Thoracic Society guideline for initiating medications for smoking cessation
- Training health professionals in smoking cessation
- USPSTF 2021 updates on effective interventions for tobacco smoking cessation in adults, including pregnant persons
- E-cigarettes and smoking cessation in real-world settings
- Interventions for quitting vaping
- Smoking cessation for people with chronic obstructive pulmonary disease
- Antidepressants for smoking cessation
- Interventions for smoking cessation in Indigenous populations: Cochrane systematic review
- Cytisine for smoking cessation
- Antidepressants for smoking cessation
- Postdischarge tobacco cessation intervention results in higher quit rates for hospitalized smokers
- Smoking cessation interventions for smokers with current or past depression: Cochrane systematic review
- Relapse prevention interventions for smoking cessation
- Differences in the effectiveness of individual‐level smoking cessation interventions by socioeconomic status
- Interventions for smoking cessation and reduction in individuals with schizophrenia
- Interventions for smoking cessation in hospitalised patients
- Cytisine unable to demonstrate noninferiority to varenicline, but is still an option for smoking cessation
- Varenicline for smoking cessation
- Factors influencing the uptake and use of nicotine replacement therapy and e‐cigarettes in pregnant women who smoke: a qualitative evidence synthesis
- Preoperative smoking cessation and postoperative complications
- Inpatient smoking cessation strategy promising, but effects aren't long lasting
- Varenicline and bupropion and suicidal behaviour
- Relapse prevention interventions for smoking cessation
- USPSTF 2020 recommends education/counseling to prevent tobacco use in children and adolescents (B recommendation)
- iCanQuit smartphone app is effective in helping with smoking cessation
- Individual behavioural counselling for smoking cessation
- Interventions to reduce harm from continued tobacco use
- Interventions for preoperative smoking cessation: Cochrane systematic review
- Smokers who quit smoking become less anxious
- Workplace interventions for smoking cessation
- Acupuncture for smoking cessation
- Pharmacological interventions for smoking cessation: an overview and network meta‐analysis
- Optimal smoking cessation treatments after initial treatment failure
- Pharmacological interventions for promoting smoking cessation during pregnancy
- Combined pharmacotherapy and behavioural interventions for smoking cessation
- Reduction versus abrupt cessation in smokers who want to quit: Cochrane systematic review
- Mindfulness for smoking cessation
- Acupuncture and related interventions for smoking cessation: Cochrane systematic review
- Group behaviour therapy programmes for smoking cessation
- Interventions for smokeless tobacco use cessation
- Individual behavioural counselling for smoking cessation
- Combined pharmacotherapy and behavioural interventions for smoking cessation
- Interventions for preventing weight gain after smoking cessation
- Smoking cessation in individuals with serious mental illness
- Pharmacotherapy for smoking cessation: effects by subgroup defined by genetically informed biomarkers
- Varenicline similar in effectiveness to nicotine patch
- Smoking cessation for people with chronic obstructive pulmonary disease
- Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation
- Interventions for tobacco use cessation in people in treatment for or recovery from substance use disorders
- Smoking cessation intervention for reducing disease activity in chronic autoimmune inflammatory joint diseases
- Tobacco cessation interventions for young people
- Psychosocial interventions for smoking cessation in patients with coronary heart disease
- Healthcare financing systems for increasing the use of tobacco dependence treatment
- Interventions for recruiting smokers into cessation programmes
- Print‐based self‐help interventions for smoking cessation
- Community interventions for reducing smoking among adults: Cochrane systematic review
- Interventions for tobacco use cessation in people living with HIV